CCI, SNI or SNL enhanced expression of P2Y1 receptors in DRG 1–3 days after injury.
Intrathecal MRS2500 reduced tactile allodynia in rats 1–3 days after CCI, SNI or SNL.
Intrathecal MRS2500 reduced injury-induced up-regulation of P2Y1 receptor expression.
Intrathecal MRS2500 lost antiallodynic effect when injected 14 days after injury.
Spinal P2Y1 receptors participate in the development of neuropathic pain.